These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15113367)

  • 1. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome.
    Huo TI; Wu JC; Huang YH; Chiang JH; Lee PC; Chang FY; Lee SD
    Aliment Pharmacol Ther; 2004 May; 19(9):999-1007. PubMed ID: 15113367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study.
    Huo TI; Wu JC; Lee PC; Chang FY; Lee SD
    Liver Int; 2004 Jun; 24(3):210-5. PubMed ID: 15189271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
    Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
    J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization.
    Hsu CY; Huang YH; Su CW; Lin HC; Chiang JH; Lee PC; Lee FY; Huo TI; Lee SD
    Liver Int; 2010 Jan; 30(1):77-84. PubMed ID: 19818004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis.
    Pietrosi G; Miraglia R; Luca A; Vizzini GB; Fili' D; Riccardo V; D'Antoni A; Petridis I; Maruzzelli L; Biondo D; Gridelli B
    J Vasc Interv Radiol; 2009 Jul; 20(7):896-902. PubMed ID: 19497762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
    Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
    Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoembolization in patients at high risk: results and complications.
    Kiely JM; Rilling WS; Touzios JG; Hieb RA; Franco J; Saeian K; Quebbeman EJ; Pitt HA
    J Vasc Interv Radiol; 2006 Jan; 17(1):47-53. PubMed ID: 16415132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival.
    Grieco A; Marcoccia S; Miele L; Marmiroli L; Caminiti G; Ragazzoni E; Cotroneo AR; Cefaro GA; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2003; 50(49):207-12. PubMed ID: 12630024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiency.
    Hsu CY; Huang YH; Su CW; Chiang JH; Lin HC; Lee PC; Lee FY; Huo TI; Lee SD
    J Clin Gastroenterol; 2010 Sep; 44(8):e171-7. PubMed ID: 20048685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.
    Brown DB; Fundakowski CE; Lisker-Melman M; Crippin JS; Pilgram TK; Chapman W; Darcy MD
    J Vasc Interv Radiol; 2004 Nov; 15(11):1209-18. PubMed ID: 15525739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute renal failure as a complication of transarterial chemoembolization in a patient with hepatocellular carcinoma].
    La Spada E; La Spada M; Brusca T; Campagna ME; Di Gesaro V; Terranova A; Sandonato L; Soresi M
    Recenti Prog Med; 2007 Apr; 98(4):232-5. PubMed ID: 17547360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk.
    Kothary N; Weintraub JL; Susman J; Rundback JH
    J Vasc Interv Radiol; 2007 Dec; 18(12):1517-26; quiz 1527. PubMed ID: 18057286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors.
    Mondazzi L; Bottelli R; Brambilla G; Rampoldi A; Rezakovic I; Zavaglia C; Alberti A; Idèo G
    Hepatology; 1994 May; 19(5):1115-23. PubMed ID: 7513677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
    Kawaoka T; Aikata H; Takaki S; Katamura Y; Hiramatsu A; Waki K; Takahashi S; Hieda M; Toyota N; Ito K; Chayama K
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):687-94. PubMed ID: 19444503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey.
    Huo T; Huang YH; Wu JC; Chiang JH; Lee PC; Chang FY; Lee SD
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1301-8. PubMed ID: 15191512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatment.
    Huo TI; Wu JC; Lui WY; Huang YH; Lee PC; Chiang JH; Chang FY; Lee SD
    Am J Gastroenterol; 2004 Aug; 99(8):1479-87. PubMed ID: 15307864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic factors for survival following transarterial chemoembolization in advanced hepatocellular carcinoma].
    Alvarez R; Bañares R; Echenagusía A; Carneros JA; Santos L; Simó G; Camúñez F
    Gastroenterol Hepatol; 2000 Apr; 23(4):153-8. PubMed ID: 10863854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute kidney injury after transarterial chemoembolization for hepatocellular carcinoma: a retrospective analysis.
    Park J; Chung HC; Lee JS; Lee BM; Kim DM; Hwang JC; Jo MW; Noh M; Shin JW
    Blood Purif; 2008; 26(5):454-9. PubMed ID: 18810227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
    Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does postembolization fever after chemoembolization have prognostic significance for survival in patients with unresectable hepatocellular carcinoma?
    Shim JH; Park JW; Choi JI; Kim HB; Lee WJ; Kim CM
    J Vasc Interv Radiol; 2009 Feb; 20(2):209-16. PubMed ID: 19084432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.